Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.
Analysis of clonotypic immunoglobulin M (IgM) from 15 patients with Waldenstrom macroglobulinemia (WM) showed a strong preferential use of the VH3/JH4 gene families. Identification of the WM IgM V/D/J was validated using single-cell analysis, confirming its presence in most B cells. Despite the extensive hypermutated VH genes in 13 of 15 patients, statistical analysis of framework/complementary-determining region (FR/CDR) mutation patterns suggests that they might have escaped antigenic selection. Neither intraclonal diversity nor isotype switching was detectable. Membranous and secreted forms of clonotypic IgM transcripts were present in bone marrow and blood. Single-cell analysis showed that clonotypic B cells coexpress CD20, surface IgM (sIgM), and sIgD but that they lack CD138. Most B cells lacked memory marker CD27 despite their hypermutated variable regions otherwise suggestive of memory status. At diagnosis, circulating B cells in WM are largely clonotypic. However, when monoclonal IgM levels are decreased, clonotypic frequencies are substantially reduced despite elevated CD20+ cells, shown to be polyclonal by DNA sequencing and CDR3 fragment analysis. Thus, WM includes the expansion of circulating, polyclonal B cells. Overall, this work suggests that WM may originate from a largely VH3-restricted, somatically mutated, predominantly CD27(-)IgM(+)IgD+ population that cannot undergo class switching, suggestive of B cells that might have bypassed the germinal center.
Kriangkum
Jitra
J
Department of Medicine, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Taylor
Brian J
BJ
Treon
Steven P
SP
Mant
Michael J
MJ
Belch
Andrew R
AR
Pilarski
Linda M
LM
D000941:Antigens / Q000737:chemistry; D018951:Antigens, CD20 / Q000096:biosynthesis; D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism; D022801:Complementarity Determining Regions / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D005803:Genes, Immunoglobulin; D006801:Humans; D007075:Immunoglobulin M / Q000737:chemistry / Q000235:genetics*; D007135:Immunoglobulin Variable Region; D007156:Immunologic Memory; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D008957:Models, Genetic; D009154:Mutation; D011509:Proteoglycans / Q000096:biosynthesis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D053668:Syndecan-1; D053667:Syndecans; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000096:biosynthesis; D045567:VDJ Recombinases / Q000235:genetics*; D008258:Waldenstrom Macroglobulinemia / Q000235:genetics / Q000276:immunology*
D000941:Antigens; D018951:Antigens, CD20; D022801:Complementarity Determining Regions; D007075:Immunoglobulin M; D007135:Immunoglobulin Variable Region; D008562:Membrane Glycoproteins; D011509:Proteoglycans; C508241:SDC1 protein, human; D053668:Syndecan-1; D053667:Syndecans; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; D004247:DNA; D045567:VDJ Recombinases